Reduced indinavir exposure during pregnancy-Reference-Cited by-同舟云学术

Reduced indinavir exposure during pregnancy

Published:2013-08-20 Issue:3 Volume:76 Page:475-483
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Cressey Tim R.,Best Brookie M.¹,Achalapong Jullapong²,Stek Alice³,Wang Jiajia⁴,Chotivanich Nantasak⁵,Yuthavisuthi Prapap⁶,Suriyachai Pornnapa⁷,Prommas Sinart⁸,Shapiro David E.⁴,Watts D. Heather⁹,Smith Elizabeth¹⁰,Capparelli Edmund¹,Kreitchmann Regis¹¹,Mirochnick Mark¹²,

Affiliation:

1. University of California, San Diego School of Medicine and Skaggs School of Pharmacy & Pharmaceutical Sciences; San Diego; CA; USA

2. Chiang Rai Prachanukroh Hospital; Chiang Rai; Thailand

3. University of Southern California School of Medicine; Department of Obstetrics and Gynecology; Los Angeles; CA

4. Center for Biostatistics in AIDS Research; Harvard School of Public Health; Boston; MA; USA

5. Chonburi Hospital; Chonburi; Thailand

6. Prapokklao Hospital; Chantaburi; Thailand

7. Phayao Hospital; Phayao; Thailand

8. Bhumibol Adulyadej Hospital; Bangkok; Thailand

9. Eunice Kennedy Shriver; National Institute of Child Health & Development (NICHD); Bethesda; MD; USA

10. National Institute of Allergy and Infectious Diseases (NIAID); Bethesda; MD; USA

11. Irmandade da Santa Casa de Misericordia de Porto Alegre; Porto Alegre; Brazil

12. Boston University; School of Medicine; Boston; MA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12078/fullpdf

Reference21 articles.

1. Pharmacokinetics of antiretrovirals in pregnant women;Mirochnick;Clin Pharmacokinet,2004

2. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States 2011 1 207 http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf

3. Atazanavir pharmacokinetics with and without tenofovir during pregnancy;Mirochnick;J Acquir Immune Defic Syndr,2011

4. Reduced lopinavir exposure during pregnancy;Stek;Aids,2006

5. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team;Hammer;N Engl J Med,1997

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field;The Journal of Clinical Pharmacology;2023-06

2. Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy;The Journal of Clinical Pharmacology;2020-08-14

3. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019;American Journal of Obstetrics & Gynecology MFM;2020-08

4. Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?;Clinical Pharmacokinetics;2020-07-22

5. Drug dosing during pregnancy—opportunities for physiologically based pharmacokinetic models;Journal of Pharmacokinetics and Pharmacodynamics;2020-06-26